Advertisement FDA approves Mylan's ANDA for granisetron hydrochloride tablets - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

FDA approves Mylan’s ANDA for granisetron hydrochloride tablets

Mylan has received final approval from the FDA for its abbreviated new drug application for granisetron hydrochloride tablets, 1mg.

Granisetron hydrochloride tablets are the generic version of Roche’s Kytril tablets and will be shipped immediately.